This cross-sectional study investigated the association between circulating leptin levels and the presence of hepatic steatosis and fibrosis, as assessed by FibroScan, in a selected cohort of individuals that were overweight and obese, not in treatment with drugs, and without clinically known liver disease. This evidence concerns the gene LEP and fatty liver disease.